Infliximab paediatric crohn's disease educational plan a European, cross-sectional, multicentre evaluation:

@article{Arana2010InfliximabPC,
  title={Infliximab paediatric crohn's disease educational plan a European, cross-sectional, multicentre evaluation:},
  author={Alejandro Arana and Sam J Allen and Joerg Burkowitz and Valerio Fantoni and Ola Ghatnekar and Mar{\'i}a Teresa Rico and Nathalie Vanhaverbeke and Charles E Wentworth and Max Brosa and F{\'e}lix M Arellano},
  journal={Drug safety},
  year={2010},
  volume={33 6},
  pages={489-501}
}
BACKGROUND The infliximab (Remicade; Schering-Plough, Kenilworth, NJ, USA) Risk Management Plan included the development, execution and tracking of an education programme directed towards prescribers of infliximab for patients with paediatric Crohn's disease (the Infliximab Paediatric Crohn's Disease Educational Plan). The programme content consisted of educational materials and communications aimed at educating prescribers on the risks associated with infliximab use. OBJECTIVE To evaluate… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Crohn's disease in Stockholm County during 1990-2001: an epidemiological update.

World journal of gastroenterology • 2006
View 3 Excerpts
Highly Influenced

A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92).

Scandinavian journal of gastroenterology • 1996
View 3 Excerpts
Highly Influenced

[Data on the epidemiology of Crohn disease in the city of Cologne].

Medizinische Klinik • 1993
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…